Grupo Galego de Investigación en Oncoloxía de Precisión
ONCOGAL
Hospital Universitario Central de Asturias
Oviedo, EspañaPublications in collaboration with researchers from Hospital Universitario Central de Asturias (5)
2023
2022
-
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study
Future oncology (London, England), Vol. 18, Núm. 35, pp. 3913-3927
2021
2019
-
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)
Scientific Reports
-
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1